CollPlant Biotechnologies Ltd
CLGN- Exchange
- Nasdaq
- Industry
- Orthopedic, Prosthetic & Surgical Appliances & Supplies
- SEC CIK
- 0001631487
No open-market purchases or sales by CollPlant Biotechnologies Ltd insiders were filed in the last 90 days; 16 institutions reported holding it in 13F filings for Q2 2026, worth $582.4K in total; no superinvestor holds it.
Q2 2025 vs. Q1 2025
How the institutions holding CollPlant Biotechnologies Ltd changed between Q1 2025 and Q2 2025.
All holders in Q2 2025All holders in Q1 2025
| Measure | Q1 2025 | Q2 2025 | Change |
|---|---|---|---|
| Holders | 16 | 18 | +2 |
| Shares | 1.29M | 1.88M | +586.4K (+45.4%) |
| Value | $3.33M | $2.53M | −$799.4K (−24.0%) |
New holders (4)
Institutions that held CollPlant Biotechnologies Ltd at the end of Q2 2025 but not at the end of Q1 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Heights Capital Management, Inc | 275,082 | $376.9K | 0.12% |
| Anson Funds Management LP | 159,401 | $216.8K | 0.04% |
| Two Sigma Securities, LLC | 10,349 | $14.1K | 0.00% |
| Simplex Trading, LLC | 93 | $0 | 0.00% |
Sold out (2)
Institutions that held CollPlant Biotechnologies Ltd at the end of Q1 2025 and filed for Q2 2025 without it.
| Institution | Shares, Q1 2025 | Value, Q1 2025 |
|---|---|---|
| UBS Group AG | 24,074 | $62.1K |
| Royal Bank of Canada | 500 | $1.00K |